News Snapshot:
|A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's headquarters in Tianjin, following an outbreak of the coronavirus disease (COVID-19), China Aug 17, 2020. (Photo: Reuters/Thomas Peter)| [Asia News = Reporter Reakkana] BEIJING: Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday (Apr 4) that its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical products regulator to enter clinical trials, Reuters reported. Unlike other major countries, China is yet to approve any foreign-made mRNA vaccines such as that produced by US-German duo Pfizer Inc and BioNTech SE....
